Vetbiolix aims to develop innovative products for treatment and prevention of diseases affecting Pets.
As pharmaceutical and biotech companies research novel molecules and compounds for human medicine, tests in different species often reveal exciting possibilities for pets. Vetbiolix has developed a unique approach focused on turning this potential into innovative therapeutic solutions for pets. Because, surprisingly, veterinarians have few therapeutics at their disposal that have been specifically developed and approved for pets.
Vetbiolix focus exclusively on clinical development of First-in-class drug-candidates for pets in Periodontitis, Osteoarthritis and Gut Motility Disorders.
